Results 61 to 70 of about 32,279 (194)

Cabozantinib for progressive metastatic medullary thyroid cancer: a review

open access: yesTherapeutics and Clinical Risk Management, 2014
Joshua R Colombo, Richard O Wein Department of Otolaryngology, Head and Neck Surgery, Tufts Medical Center, Boston, MA, USA Abstract: Medullary thyroid cancer is uncommon and patients typically present with advanced disease.
Colombo JR, Wein RO
doaj  

Rising CEA Levels in a Patient with Colon Carcinoma: Metachronous Medullary Thyroid Cancer

open access: yesThe International Journal of Biological Markers, 2014
Introduction Carcinoembryonic antigen (CEA) is a commonly used tumor marker, and its value in colon cancer is well established. However it is overexpressed in many different tumors.
Sema Sezgin Göksu MD   +3 more
doaj   +1 more source

A case report of non‐syndromic colonic ganglioneuroma in a patient with juvenile polyposis

open access: yesJPGN Reports, EarlyView.
Abstract Colonic ganglioneuromas in children are rare, particularly without associated hereditary syndromes like multiple endocrine neoplasia (MEN2B), neurofibromatosis type 1(NF1), or Phosphatase and tensin homolog hamartoma tumor syndrome (PHTS). We report a 12‐year‐old male with a history of juvenile polyposis syndrome (JPS) and segmental colonic ...
Holly Coffey   +2 more
wiley   +1 more source

Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report

open access: yesCurrent Problems in Cancer: Case Reports, 2020
Medullary thyroid cancer is a neuroendocrine tumor of the thyroid gland and its frequency is 1–2% among all thyroid cancers. Their prognosis is poor with a 10-year survival rate of 40%.
Yusuf Ilhan   +3 more
doaj   +1 more source

Familial Medullary Thyroid Cancer: Five-year Review of the Most Frequent Mutations in the RET Gene: An Update

open access: yesSudan Journal of Medical Sciences, 2022
Background: Familial Medullary Thyroid Cancer (FMTC) is hereditary in 25% of cases. Patients with an inherited form of FMTC usually have a germline mutation in the RET proto-oncogene (10q11.2); these mutations generally occur in exons 10 (codons 618 and ...
Blanca Estela Díaz Castañeda   +4 more
doaj   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Significance of laboratory markers in the diagnosis and postoperative monitoring of patients with medullary thyroid cancer

open access: yesКубанский научный медицинский вестник, 2014
The histologic picture of the medullary cancer can resemble a papillary and follicular cancer that takes away doctors towards the wrong statement of the diagnosis.
L. A. Ivanova   +5 more
doaj  

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?

open access: yesBMC Endocrine Disorders, 2019
Background Medullary thyroid carcinoma is a neuroendocrine tumor belonging form a malignant growth of the thyroid parafollicular C-cells, representing from 1 to 10% of all thyroid cancer.
Claudio Gambardella   +12 more
doaj   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

The Role of Thyroidectomy in the Management of Thyroglossal Duct Carcinoma: A Systematic Review

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective The extent of surgical management of thyroglossal duct‐associated differentiated thyroid carcinoma remains controversial. This study aims to evaluate the role of total thyroidectomy in patients with thyroglossal duct‐associated differentiated thyroid carcinoma and provide insights to support individualized, evidence‐based care.
Hidde H. IJtsma   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy